Press Releases

Sep 27, 2018

Veracyte Announces New Data Reinforcing Clinical Value of Genomic Tests In Lung Disease Diagnoses to Be Presented at CHEST Annual Meeting 2018

Read More

Sep 26, 2018

Veracyte Announces Multiple Studies to Be Presented at ATA Annual Meeting Demonstrating “Real World” Performance of Afirma GSC and Xpression Atlas in Thyroid Cancer Diagnosis

Read More

Aug 30, 2018

Veracyte Achieves Major Medicare Milestone for the Envisia Genomic Classifier

Read More

Aug 30, 2018

Veracyte to Present at the Morgan Stanley 16th Annual Global Healthcare Conference

Read More

Aug 29, 2018

Veracyte Names Angeline McCabe as Vice President, Investor Relations and Corporate Communications

Read More

Jul 30, 2018

Veracyte to Present at the Canaccord Genuity 38th Annual Growth Conference

Read More

Jul 30, 2018

Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read More

Jul 25, 2018

Veracyte Announces Pricing of Public Offering of 5,000,000 Shares of Common Stock

Read More

Jul 24, 2018

Veracyte Announces Proposed Public Offering of Common Stock

Read More

Jul 23, 2018

Veracyte Announces Second Quarter 2018 Financial Results

Read More